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Purpose: To investigate the phenotypic variability of patients bearing the heterozygous R124H mutation in the TGFBI
(transforming growth factor-beta-induced) gene that causes granular corneal dystrophy type 2 (GCD2).
Methods: We describe the phenotypic range of GCD2 heterozygotes for the common R124H mutation in TGFBI; seven
with an extremely mild phenotype and six with an extremely severe phenotype. Detailed slit-lamp photographs of these
patients were generated. All patients had no history of ocular surgery and were diagnosed as being heterozygous for GCD2
by DNA analysis from peripheral blood. Expression levels of transforming growth factor-beta-induced protein (TGFBIp)
were compared among cultured corneal fibroblasts from ten normal donors.
Results: We report profound differences in the severity of the phenotype across our case series. Two patients with a mild
phenotype were diagnosed as unaffected at presentation; however follow-up examinations revealed granular deposits.
Importantly, we also observed familial clustering of phenotypic variance; five patients from two families with a mild
phenotype showed a similarly mild phenotype within family members. Similarly, six patients from two families with
severe phenotypes showed corneal deposits with similar patterns and severity within each distinct family, but distinct
patterns between families. TGFBIp expressions from different donor derived cultured corneal fibroblasts were different
between one another.
Conclusions: GCD2 heterozygotes have extremely varied phenotypes between individual patients. However phenotypes
were broadly consistent within families, suggesting that the observed variable expressivity might be regulated by other
genetic factors that could influence the abundance of TGFBIp or the function of the pathway. From a clinical perspective,
our data also highlighted that genetic analysis and meticulous slit-lamp examination in both eyes at multiple time intervals
is necessary.
Granular corneal dystrophy type 2 (GCD2), also known
as Avellino corneal dystrophy, is an autosomal dominant
disorder caused by a mutation in codon 124 of the
transforming growth factor-beta-induced (TGFBI) gene, in
which histidine replaces arginine (R124H). Holland et al. [1]
reported characteristics of deposits in GCD2 heterozygotes as
being detectable early in life, from age 6 to 16, while granular
deposits in the superficial stromal layer and lattice deposits in
the deep stroma are detected later, over the age of 35. Diffuse
anterior stromal haze can be observed in some patients over
50 years. Usually, granular and lattice corneal deposits slowly
increase in size and number with age, and visual impairment
occurs later in life. By contrast, the phenotype of GCD2
homozygotes has been reported as earlier onset, from age 3 to
5, with dense and confluent granular deposits which
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aggressively progress with age [2,3], indicative of a dosage
effect.
Although the roles of the R124H mutation in generating
GCD2 is now well documented, both prospective and
retrospective clinical analyses have begun to uncover
significant variability in clinical expressivity that is as yet
poorly defined and understood. Konishi et al. [4] reported that
two distinct opacity patterns were observed in GCD2
heterozygotes: the typical, common type as observed by
Holland et al. [1], and a diffuse subepithelial opacity dominant
type. Rosenwasser et al. [5] also reported that variable
proportions of granular and lattice deposits, whether granular
dominant or lattice dominant, were observed within the same
family and among different families. However, the extent of
variation has not been discussed widely, especially with
regard to a) extreme cases; and b) comparisons of inter- versus
intra-familial variability.
In this study, we draw from the phenotypic analysis of
~900 GCD2 heterozygotes and report the cases which
represent the extreme ranges of the phenotype. In addition to
documenting the phenotype with detailed slit-lamp
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photography, we also show significant familial clustering.
This suggests that a shared biologic mechanism underpins
variable expressivity. These observations will contribute to
the improved diagnosis and management of patients,
especially in the context of refractive surgery candidates.
Further, our studies suggest that additional factors are likely
to modulate the penetrance and expressivity of primary causal
TGFBI mutations.
METHODS
Clinical evaluation of patients: A total of 906 GCD2
heterozygotes, confirmed genetically with DNA sequencing
from 160 unrelated families were examined and photographed
with a slit-lamp camera (D2X, Nikon Corporation, Tokyo,
Japan) from January 2006 to August 2011 at Yonsei
University Medical Center, Seoul, Korea. DNA sequencing
for the TGFBI locus was performed as reported [4,6,7].
Genomic DNA was extracted from the peripheral leukocytes
of the patients using a QIAamp DNA Blood Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s protocol.
Exon 4 for the R124H mutation of TGFBI was analyzed by
polymerase chain reaction (PCR) amplification using Maxime
PCR PreMix Kit (Cat. No. 25167; Gentaur, San Jose CA). The
reaction mixture was amplified as follows: 5 min at 95 °C; 30
cycles of 94 °C for 30 s, 58 °C for 30 s, and 72 °C for 30 s;
and 72 °C for 7 min. The oligonucleotide primers are listed in
Table 1. Sequencing conditions were as follows; 90 s at 95
°C; 25 cycles of 95 °C for 30 s, 50 °C for 5 s, and 60 °C for 4
min. The products of the sequencing reaction were analyzed
using a fluorescent ABI 3730 XL (Applied Biosystems, Foster
City, CA). Nearly all the participants showed a typical
phenotype of GCD2, with features of early onset granular
deposits, late onset lattice deposits, and often diffuse haze in
individuals older than 50. Within our cases, we found seven
with an extremely mild phenotype and six with an extremely
severe phenotype; since these represented the extreme
phenotypes among our cases, they were selected for the
present report. Clinical characteristics including age, gender,
usage of eyeglasses or contact lenses, type of contact lens,
occupation, and workplace were documented.
Immunoblot analysis: To find differences in the expression of
transforming growth factor-beta-induced protein (TGFBIp),
a major component of GCD2 corneal deposits, western blot
analysis of primary cultured corneal fibroblasts was
performed on ten different donated normal corneas. Corneas
were collected from a 37 year-old man (normal corneal
fibroblasts (NCF-1), a 62 year-old man (NCF-2), a 20 year-
old woman (NCF-3), a 46 year-old man (NCF-4), a 29 year-
old man (NCF-5), a 60 year-old man (NCF-6), a man with
unknown-age (NCF-7), a woman with unknown-age
(NCF-8), a 69 year-old woman (NCF-9), and an 81 year-old
man (NCF-10). We first performed western blot analysis of
four corneas (Figure 1A) to find out the variable expression
level of TGFBIp from NCF-1, 2, 3, and 4 and the expression
level was very low in NCF-3. We performed western blot
analysis of another six corneas from normal donors (Figure
1B). Western blot analysis of NCF-4 was repeated in the
second experiment to allow comparison between the two
separate experiments.
To measure the level of TGFBIp expression, total cellular
protein was electrophoresed on Tris-glycine SDS
polyacrylamide gels. Equal amounts of proteins were then
transferred onto polyvinylidene difluoride membranes
(Millipore Corp., Bedford, MA), blocked in 5% dry milk in
Tris-buffered saline containing Tween-20 (TBS-T) at room
temperature for one hour, and then incubated with primary
antibodies to TGFBIp (0.2 µg/ml; Cat. No. AF2935; R&D
Systems, Minneapolis, MN) and β-actin (1:5,000 dilution;
Cat. No. A-5441; Sigma, St Louis, MO) overnight at 4 °C.
After three washes with TBS-T, blots were incubated with
secondary antibodies conjugated to horseradish peroxidase at
room temperature for 1 h. Horseradish peroxidase-linked anti-
mouse IgG (1:5,000 dilution; Cat. No. 31460) or anti-goat IgG
(1:5,000 dilution; Cat. No. 31430) were used as a secondary
antibody (Pierce, Rockford, IL). Western blots were
visualized using the enhanced chemiluminescence system
(Pierce).
This study was approved by the Severance Hospital
Institutional Review Board and informed consent was
obtained from all subjects participating in this study.
RESULTS
The extreme range of mild R124H phenotypes:
Patient 1—A 48 year-old woman with several discrete
granular corneal deposits visited our clinic with her daughter
for evaluation of corneal dystrophy. Her 23 year-old daughter,
determined to be a GCD2 R124H heterozygote, had best
corrected visual acuity (BCVA) 20/20 in both eyes and
showed no corneal deposit (Figure 2A,B). The patient had no
history of glasses or contact lens wear. Upon reexamination
six months later, the daughter showed one small corneal
TABLE 1. PCR PRIMER PAIRS.
Accession number Primer sequence (5'-3') Product size
(bp)
Annealing temp.
(°C)
NM_000358 Forward-CCCCAGAGGCCATCCCTCCT 224 58
 Reverse-CCGGGCAGACGGAGGTCATC   
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deposit in the right eye (white arrow, Figure 2C) and none in
the left (Figure 2D).
Patient 2—A 28 year-old man was evaluated for corneal
dystrophy because his older sister was diagnosed as being a
GCD2 homozygote. He had used glasses for eight years. Upon
initial examination, granular deposits or diffuse haziness were
not observed in either eye (datanot shown). 8pon
reexamination two years later, due to DNA analysis that
showed him to be a GCD2 heterozygote, a newly developed,
faint granular deposit was observed in each eye (data not
shown).
Patients 3 and 4 (Mild family I)—A 22 year-old woman
(Patient 3) presented with coincidentally found corneal
deposits. She had used glasses for ten years and soft contact
lenses for five years. On presentation, BCVA was 20/20 in the
right eye and 20/25 in the left eye. A granular deposit was
observed around the pupillary margin at 7 o’clock in the right
eye and a faint opacity was observed at 9 o’clock in the left
eye (black arrowheads, Figure 3A,B). Her mother, a 47 year-
old woman (Patient 4), showed a few granular corneal
deposits (Figure 3C,D). She had used soft contact lenses for
approximately 14 h per day for 30 years.
Patients 5, 6, and 7 (Mild family II)—A 33 year-old
woman (Patient 5) was referred with minimal corneal deposits
found preoperatively for refractive surgery. She had used
glasses for 20 years, with rare contact lens use. Several
granular deposits were observed in the center of the right eye
and the left eye showed a few linear and granular deposits
(Figure 4A,B). BCVA was 20/25 in the right eye and 20/30 in
the left eye. Her 34 year-old brother (Patient 6) also had
Figure 1. Expression of transforming growth factor-beta-induced-gene protein (TGFBIp) in ten different normal corneal fibroblasts (NCF).
A, B: western blots show evidence of differential expression of TGFBIp in cultured NCF-1 (37 year-old man), NCF-2 (62 year-old man),
NCF-3 (20 year-old woman), NCF-4 (46 year-old man), NCF-5 (29 year-old man), NCF-6 (60 year-old man), NCF-7 (man with unknown-
age), NCF-8 (woman with unknown-age), NCF-9 (69 year-old woman), NCF-10 (81 year-old man) from normal donor corneas. In the second
experiment, NCF-4 was reloaded for a comparison of the two separate experiments. C, D: Relative density of TGFBIp expression of A and
B, respectively. Relative density of NCF-4 was adjusted to 100% in both C and D for a comparison of the densities of normal corneal fibroblasts
in two separate experiments. Blots containing 50 μg total protein from normal corneal fibroblasts were incubated with anti-TGFBIp antibody.
TGFBIp expression was assayed using anti-TGFBIp polyclonal goat antibodies. β-actin has been used as a control for equal loading. Numbers
on the right correspond to the molecular weight markers in kilodaltons (kDa).
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several corneal deposits (Figure 4C,D). He had used glasses
for 20 years and had never used contact lenses. Her 62 year-
old father (Patient 7) had one small faint granular deposit in
the right eye and several in the left eye (black arrowheads,
Figure 4E,F). He had no glasses or contact lens history.
Patients with severe phenotypes:
Patients 8, 9, and 10 (Severe family I)—A 35 year-old
woman (Patient 8) was referred with multiple corneal deposits
disturbing vision. Diffuse, confluent, crumb-shaped granular
deposits occluded the visual axis in both eyes and numerous
lattice deposits were also observed in the deep stroma (Figure
5A,B). BCVA was 20/40 in both eyes. She had no glasses or
contact lens history. Her 38 year-old brother (Patient 9) had
similar granular and lattice deposits (Figure 5C,D). BCVA
was 20/40 in the right eye and 20/70 in the left eye; he had
used glasses for 20 years. Their 59 year old mother (Patient
10) had similar, but less severe, corneal deposits than her
daughter. She had used glasses for 30 years (Figure 5E,F).
Patients 11, 12, and 13 (Severe family II)—A 37 year-
old woman (Patient 11) was referred because of multiple
corneal deposits and decreased visual acuity. Discrete,
multiple, round, and ring-shaped granular deposits and a few
lattice deposits were observed in both eyes (Figure 6A,B). Her
sister and mother, age 40 (Patient 12) and 65 (Patient 13),
respectively, had similar multiple granular deposits bilaterally
(Figure 6C-F). Her sister had no glasses or contact lens
history. BCVA was 20/25 in the right eye and 20/70 in the left
eye. Her mother had used glasses for ten years. BCVA was
20/25 in the right eye and 20/40 in the left eye.
Differential expression of TGFBIp among cultured corneal
fibroblasts from different donors: The western blot showed
TGFBIp expression as a specific protein band of expected size
(~70 kDa) in all ten donor corneal fibroblasts. As shown in
Figure 1, TGFBIp levels were differentially expressed among
the normal corneal fibroblasts. The expression of TGFBIp was
not related to patient age. The TGFBIp expression level
detected was very low in NCF-3 (Figure 1A,C), while
Figure 2. Slit-lamp photographs and
pedigree of Patient 1 with mild
phenotype, aged 23 years. A, C: Right
eye, B, D: Left eye. A, B: At
presentation, no corneal deposits were
observed in both eyes. C, D: After six
months, one faint corneal deposit was
observed in the right eye (white arrow),
but there was still no corneal deposit in
the left eye. E: Pedigree of Patient 1.
Circles represent women, squares
represent men. The filled symbols
indicate affected individuals.
Figure 3. Slit-lamp photographs and
pedigree of mild family I. A, B: Patient
3, aged 22; C, D: Patient 4, aged 47. A,
C: Right eye, B, D: Left eye. A:
Granular opacity was observed around
pupil margin at 7 o’clock in the anterior
stroma in the right eye (black
arrowhead). B: Nearly non-detectable
corneal deposit was observed in the left
eye. C, D: A few dot-like granular
deposits (black arrowheads) were
observed centrally in the anterior stroma
in both eyes. The black arrow in the right
eye indicates the mark of a soft contact
lens. E: Pedigree of mild family I.
Circles represent women, squares
represent men. The filled symbols
indicate affected individuals.
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somewhat high in NCF-8 (Figure 1B,D). This result suggests
that TGFBIp expression may be associated with the variety of
GCD2 phenotypes.
DISCUSSION
Our findings illustrate the high degree of variability in the
amount of deposits between GCD2 heterozygotes. No
deposits could be found in a GCD2 positive 23 year-old
woman (Patient 1) and 28 year-old man (Patient 2) and only
a small number of corneal deposits were observed in other
mild phenotype patients. By contrast, all six patients
displaying the severe phenotype showed numerous deposits
occupying nearly the entire central cornea, similar to
homozygotes or patients having undergone refractive surgery
[7,8].
Recently, the possibility of incomplete penetrance of
GCD2 heterozygotes has been suggested. Cao et al. [9]
reported reduced penetrance in seven patients, four of whom,
Figure 4. Slit-lamp photographs and
pedigree of mild family II. A, B: Patient
5, aged 33; C, D: Patient 6, aged 34; E,
F: Patient 7, aged 62. A, C, E: Right eye,
B, D, F: Left eye. A: Several granular
and linear corneal opacities were
observed. B: A few small granular
deposits and linear opacities were
observed. C, D: Opacities of round and
linear shapes were observed centrally in
the anterior stroma in both eyes. E: A
small granular deposit was observed
around the pupillary margin at 12
o’clock (black arrowhead). F: Faint
granular opacities at the 1, 4, 5, and 7
o’clock positions were observed (black
arrowheads). G: Pedigree of mild family
II. Circles represent women, squares
represent men. The filled symbols
indicate affected individuals.
Figure 5. Slit-lamp photographs and
pedigree of severe family I. A, B: Patient
8, aged 35; C, D: Patient 9, aged 38; E,
F: Patient 10, aged 59. A, C, E: Right
eye, B, D, F: Left eye. Confluent
granular deposits, prominent lattice
deposits, and anterior haze occupying
the visual axis was observed in both eyes
of all family members. They showed a
more severe phenotype than other
patients of a similar age and members
within the family showed a similar
pattern. G: Pedigree of severe family I.
Circles represent women, squares
represent men. The filled symbols
indicate affected individuals.
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aged 56, 37, 23, and 21, had no detectable corneal deposits,
despite the presence of the R124H mutation. In that study, the
existence of the deposits was evaluated with slit-lamp
photographs presented to several third parties. Kim et al.
[10] reported two cases of non-penetrance of GCD2
heterozygotes, aged 26 and 55 years, diagnosed by DNA
analysis from epidermal keratinocytes obtained by adhesive
tape. Our extremely mild phenotype patients (Patients 1 and
2), having no detectable deposits, could hardly be suspected
of being heterozygotes before securing DNA diagnosis. Given
the ages of these patients, and because their relatives showed
definite GCD2 phenotypes, we failed to find even a small
corneal deposit at initial examination even though we
attempted to do so. However, follow-up of these patients
showed faint, recognizable deposits on subsequent slit-lamp
examinations.
In contrast, all the patients with a severe phenotype had
excessive corneal deposits, which resulted in visual
disturbance onset as early as the fourth decade (Patients 8, 9,
and 11); they had no other history of ocular or systemic
disease. Importantly, family members of patients displaying
extremely severe phenotypes showed similarly severe
patterns within families. However, the pattern of the disorder
was family-specific. For example, the corneas of severe
family I (Figure 5) had indistinct confluent granular deposits,
prominent lattice deposits, and anterior haze in corneal
stroma, while the affected corneas in severe family II (Figure
6) had numerous distinct granular deposits with a small
number of lattice deposits.
The phenotypic range reported here presents a challenge
for diagnosis and management due to the extreme variable
penetrance and expressivity observed both by ourselves and
other ophthalmologists. In our experience, the combination of
genotypic data at the TGFBI locus and careful slit-lamp
examinations at multiple time points are necessary to manage
these patients accurately.
Our data also indicate that, within the observed
phenotypic range, there is a distinct clustering of phenotypes
within families which can be explained both by shared genetic
factors and environmental exposure. In our study groups, we
did not discern any extraordinary habits, including excessive
outdoor activity (Table 2). Longitudinal studies of larger study
groups will be required to investigate possible environmental
contributions more thoroughly.
There is no established method to prevent the
development or progression of corneal deposits in GCD2
patients so far. However, contact lenses have been suggested
as a possible anti-aggravation factor. Severin et al. [11] and
Rosters et al. [12] reported that soft contact lens wear had
prevented the recurrence of granular deposits in eyes that had
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Figure 6. Slit-lamp photographs and pedigree of severe family II. A, B: Patient 11, aged 37; C, D: Patient 12, aged 40; E, F: Patient 13, aged
65. A, C, E: Right eye, B, D, F: Left eye. Numerous granular corneal deposits were observed in both eyes of all family members. They showed
a more severe phenotype than other patients of a similar age and members within the family showed a similar pattern. G: Pedigree of severe
family II. Circles represent women, squares represent men. The filled symbols indicate affected individuals.
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undergone penetrating keratoplasty for 14 years and 53
months, respectively. These authors hypothesized that the
interaction between the contact lens and cornea altered corneal
metabolism and resulted in a delay, or prevention, of
recurrence [12]. In the present study, Patients 3 and 4 had been
using soft contact lenses for 5 years and 30 years, respectively,
and showed a mild phenotype which may be expected from
the results of the previous study. However, other patients in
this study with a mild phenotype had never used contact lenses
(Table 2). Contact lens wear may be one of the factors in
preventing the recurrence or progression of corneal deposits
in certain patients, but the mild phenotype of virgin GCD2
heterozygotes in this study could not be explained solely by
the use of contact lenses. Further studies would be helpful in
determining the effect of contact lenses on corneal deposits.
In addition to the individual phenotype variations, we
observed age-independent severity within families as some
previous studies reported [1,5,13]. While aging is the most
well known progression factor [1], the youngest family
member (Patients 5, 8, and 11) in each family showed more
severe expressivity in comparison to the oldest family
member (Patients 7, 10, and 13), suggesting that the presence
of an R124H mutation of the TGFBI gene and aging cannot
solely explain phenotype severity.
In this study, we analyzed the expression of TGFBIp
among ten different normal corneas and the expression of
TGFBIp showed individual differences (Figure 1). The
expression of TGFBIp was not related to patient age, because
similar amounts of TGFBIp were expressed in both NCF-2
(aged 62) and NCF-4 (aged 46). These findings suggest
expression differences of TGFBIp between GCD2 patients
might exist and could serve as another possible reason for
phenotype variation seen between both extremely mild and
severe GCD2 patients and between individuals within
families.
In conclusion, GCD2 heterozygotes have a highly
variable phenotype, which can pose a challenge for securing
clinical diagnosis, especially for mild cases. Our data suggest
that offering prospective genetic screening in relatives of
GCD2 patients has potential clinical value in securing sub-
clinical phenotypes when coupled with meticulous slit-lamp
examination and long-term observation.
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